Comment on primary effectiveness of rituximab plus chemotherapy in treating CD 20 + non hodgkin lymphoma
Original article | No. 17 (2013)
Journal of Clinical Medicine Hue Central Hospital, No. 17 (2013)
Original article

Comment on primary effectiveness of rituximab plus chemotherapy in treating CD 20 + non hodgkin lymphoma

DOI: 10.38103.17.33
10.38103.17.33
  • Le Thi Khanh Tam
  • Nguyen Thi Thai Hoa
Le Thi Khanh Tam
Nguyen Thi Thai Hoa

Downloads

Download data is not yet available.
PDF (Tiếng Việt)     47    52

Abstract

.

https://doi.org/10.38103.17.33

References

.

Published 18-02-2025
Fulltext
PDF (Tiếng Việt)     47    52
Language
Tiếng Việt
Issue No. 17 (2013)
Section Original article
DOI 10.38103.17.33
Keywords
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital

Tam, L. T. K., & Hoa, N. T. T. (2025). Comment on primary effectiveness of rituximab plus chemotherapy in treating CD 20 + non hodgkin lymphoma. Journal of Clinical Medicine Hue Central Hospital, 5(17), 191–195. https://doi.org/10.38103.17.33
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
© 2024 Hue Central Hospital - Designed by OJSVN